NANJING, China, May 24, 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the annual general meeting of shareholders (the "Meeting") will be held on Thursday, June 9, 2011 at 10 a.m. Beijing time. The meeting will be held in No.699-18, Xuanwu Avenue, Xuanwu District, Nanjing, the People's Republic of China.
The meeting's main purposes are:
This notice and other information with regards to the Meeting are available on the investor relation section of the Company's website: www.simcere.com.
About Simcere Pharmaceutical Group
Simcere Pharmaceutical Group ("Simcere") (NYSE: SCR) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com.
|
Investor and Media Contacts: Email: ir@simcere.com |
||
|
In Nanjing: Yehong Zhang President Simcere Pharmaceutical Group Tel: 86-25-8556-6666 ext 8811 |
In the United States: Kate Tellier Brunswick Group LLC Tel: 1-212-333-3810 |
|
|
In Beijing: Yue Yu Brunswick Group Tel: 86-10-5960-8600 |
In Hong Kong: Joseph Lo Chi-Lun Brunswick Group Tel: 852-3512-5000 |
|
